Anti-inflammatory activity of lefamulin versus azithromycin and dexamethasone in vivo and in vitro in a lipopolysaccharide-induced lung neutrophilia mouse model

• Michael Hafner,

  Roles Conceptualization, Formal analysis, Methodology, Writing – review & editing

  Affiliation Nabriva Therapeutics GmbH, Vienna, Austria

  ⨯
• Susanne Paukner,

  Roles Conceptualization, Formal analysis, Methodology, Writing – review & editing

  Affiliation Nabriva Therapeutics GmbH, Vienna, Austria

  ⨯
• Wolfgang W. Wicha,

  Roles Conceptualization, Formal analysis, Methodology, Resources, Writing – review & editing

  Affiliation Nabriva Therapeutics GmbH, Vienna, Austria

  ⨯
• Boška Hrvačić,

  Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Resources, Writing – review & editing

  Affiliation Fidelta Ltd, Zagreb, Croatia

  ⨯
• Matea Cedilak,

  Roles Data curation, Formal analysis, Investigation, Methodology, Resources, Writing – review & editing

  Affiliation Fidelta Ltd, Zagreb, Croatia

  ⨯
• Ivan Faraho,

  Roles Data curation, Formal analysis, Investigation, Methodology, Resources, Writing – review & editing

  Affiliation Fidelta Ltd, Zagreb, Croatia

  ⨯
• Steven P. Gelone

  Roles Conceptualization, Formal analysis, Methodology, Writing – review & editing

  * E-mail: Steve.Gelone@nabriva.com

  Affiliation Nabriva Therapeutics US, Inc., Fort Washington, Pennsylvania, United States of America

  ⨯